Ved cut- off havde 46% af patienterne med kronisk CML (CML- CP) eksponeringsvarigheder på 6- 12 måneder, og 18% af patienterne havde en eksponeringsvarighed på mere end 12 måneder.
At cut-off, 46% of patients in chronic-phase CML (CML-CP) had a duration of exposure of 6 to 12 months and 18% of patients had a duration of exposure of more than 12 months.